Subscribe to Newsletter

Charlie Johnson

Charlie Johnson is CEO of ADC Bio.

Content by Charlie Johnson:

 Discovery & Development Drug Delivery

ADCs Assemble

| Charlie Johnson

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker